MedPath

Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma.

Not Applicable
Completed
Conditions
Anterior Cruciate Ligament Rupture
Interventions
Diagnostic Test: functional brain MRI
Registration Number
NCT03950024
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.

Detailed Description

AMI leads to quadriceps atrophy, persistent knee pain, dynamic instability, and a higher rate of osteoarthritis. A recent literature review suggests that the AMI phenomenon is multifactorial, but not widely known and poorly understood. Known mechanisms include impaired motor function at rest, impaired transmission of information from joint sensory receptors, impaired excitability of the spinal reflex and impaired cortical activity. Several studies have suggested a link between ACL rupture and central nervous system reorganization. Among the neurophysiological investigations explored are the evoked somesthesic potentials, electroencephalography, and transcranial magnetic stimulation (TMS). However, these mechanisms alone do not explain the phenomenon in its entirety, suggesting that there are other mechanisms. Furthermore, no study has used functional brain MRI to assess the existence of similar changes in AMI.

This study plans to compare two groups of patients with an ACL rupture: a group with AMI, and a group without AMI. Both groups will undergo a functional brain MRI in order to analyse any modification of the sensory-motor network connectivity that could occur.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
42
Inclusion Criteria
  • male patient, right-handed,
  • with a severe right knee sprain in the event of ACL rupture,
  • occurrence of trauma within 4 weeks prior to inclusion,
  • with a score of ≥ 8/10 on the Edinburgh Manual Laterality Questionnaire, -affiliated or benefiting from public health services.
Exclusion Criteria
  • person presenting any of these conditions : professional player / athlete, -contraindication to the MRI examination (claustrophobic patient, patient with a metallic element),
  • patient already operated on with ligament damage to the knee other than ACL,
  • patient with iterative ACL rupture,
  • patient who has undergone contralateral ligament reconstruction,
  • patient with multi-ligamentary knee injury,
  • patient refusing to be informed of any abnormality detected on brain MRI, -protected patient (adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
with arthrogenic Muscle Inhibitionfunctional brain MRI-
without arthrogenic Muscle Inhibitionfunctional brain MRI-
Primary Outcome Measures
NameTimeMethod
Matrix of correlation coefficientsDay 0

A matrix of correlation coefficients, measured by MRI, representing the strength of the sensory-motor network connectivity at rest for each group.

Secondary Outcome Measures
NameTimeMethod
Activation map of the motor representations of knee movementDay 0

An activation map of the motor representations of knee movement are measured by MRI

Trial Locations

Locations (1)

Pierre Paul Riquet Hospital

🇫🇷

Toulouse, Occitanie, France

© Copyright 2025. All Rights Reserved by MedPath